@article{JTD27217,
author = {Ansam Sinjab and Arafat Tfayli},
title = {Prioritizing mutational profiling for targeted therapy of lung adenocarcinoma},
journal = {Journal of Thoracic Disease},
volume = {11},
number = {Suppl 3},
year = {2019},
keywords = {},
abstract = {The Lung Cancer Mutation Consortium (LCMC) was launched as a cross-institutional effort to prospectively follow non-small cell lung cancer (NSCLC) patients across sixteen centers in the US, with a focus on genomic mutation profiles, in an effort to improve the selection of effective therapeutic courses (1).},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/27217}
}